Test ID LEFLU Leflunomide Metabolite (Teriflunomide), Serum
Useful For
Therapeutic monitoring of patients actively taking leflunomide
Assessment of elimination in patients requiring enhanced elimination of the drug
Method Name
High-Turbulence Liquid Chromatography Mass Spectrometry (HTLC-MS/MS)
Reporting Name
Leflunomide Metabolite, SSpecimen Type
Serum RedSpecimen Required
Supplies: Sarstedt Aliquot Tube, 5 mL (T914)
Collection Container/Tube:
Preferred: Red top
Acceptable: Serum gel
Submission Container/Tube: Plastic vial
Specimen Volume: 1 mL
Collection Instructions:
1. Draw blood no sooner than 12 hours (trough value) after last dose.
2. Within 2 hours of collection, centrifuge and aliquot serum into a plastic vial.
Specimen Minimum Volume
0.3 mL
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Serum Red | Ambient (preferred) | 28 days | |
Frozen | 28 days | ||
Refrigerated | 28 days |
Reference Values
Therapeutic: >40 mcg/mL
Elimination: <0.020 mcg/mL
Day(s) Performed
Monday, Wednesday, Friday
Performing Laboratory
Mayo Clinic Laboratories in RochesterCPT Code Information
80193
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
LEFLU | Leflunomide Metabolite, S | 44828-2 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
60292 | Leflunomide Metabolite, S | 44828-2 |
Test Classification
This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. It has not been cleared or approved by the US Food and Drug Administration.Report Available
3 to 5 daysNY State Approved
YesForms
If not ordering electronically, complete, print, and send a Therapeutics Test Request (T831) with the specimen.